UBS Group
ZBH icon

UBS Group’s Zimmer Biomet ZBH Stock Holding History

UBS Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,800
Closed -$1.26M – 11035
2025
Q2 		$1.26M Buy
+13,800
New +$1.33M ﹤0.01% 5239
2025
Q1 		– Sell
-12,700
Closed -$1.34M – 10784
2024
Q4 		$1.34M Hold
12,700
– – ﹤0.01% 5086
2024
Q3 		$1.37M Sell
12,700
-3,000
-19% -$327K ﹤0.01% 4351
2024
Q2 		$1.7M Sell
15,700
-4,600
-23% -$542K ﹤0.01% 3935
2024
Q1 		$2.68M Buy
+20,300
New +$2.54M ﹤0.01% 3645
2021
Q2 		– Sell
-8,858
Closed -$1.38M – 9894
2021
Q1 		$1.38M Hold
8,858
– – ﹤0.01% 3927
2020
Q4 		$1.32M Sell
8,858
-6,592
-43% -$931K ﹤0.01% 3781
2020
Q3 		$2.04M Hold
15,450
– – ﹤0.01% 3015
2020
Q2 		$1.79M Buy
15,450
+8,034
+108% +$926K ﹤0.01% 2982
2020
Q1 		$728K Hold
7,416
– – ﹤0.01% 3635
2019
Q4 		$1.08M Buy
+7,416
New +$1.02M ﹤0.01% 4139
2019
Q3 		– Sell
-2,781
Closed -$318K – 8304
2019
Q2 		$318K Sell
2,781
-22,866
-89% -$2.68M ﹤0.01% 4614
2019
Q1 		$3.18M Buy
+25,647
New +$2.91M ﹤0.01% 2582
2018
Q1 		– Sell
-2,266
Closed -$265K – 8220
2017
Q4 		$265K Buy
+2,266
New +$256K ﹤0.01% 4728
2017
Q3 		– Sell
-86,314
Closed -$10.8M – 8044
2017
Q2 		$10.8M Buy
+86,314
New +$10.2M 0.01% 1474
2017
Q1 		– Sell
-11,611
Closed -$1.16M – 8036
2016
Q4 		$1.16M Buy
+11,611
New +$1.24M ﹤0.01% 3421
2016
Q2 		– Sell
-11,351
Closed -$1.18M – 8013
2016
Q1 		$1.18M Buy
11,351
+11,248
+10,920% +$1.09M ﹤0.01% 3115
2015
Q4 		$10K Hold
103
– – ﹤0.01% 7290
2015
Q3 		$9K Hold
103
– – ﹤0.01% 7353
2015
Q2 		$11K Hold
103
– – ﹤0.01% 7404
2015
Q1 		$12K Buy
+103
New +$11.8K ﹤0.01% 7507

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's ZBH Position: Q1 2026 in Review

UBS Group increased its Zimmer Biomet (ZBH) stake by 68% in Q1 2026, buying an estimated $51M and bringing the position to 1,373,365 shares worth $124M. The position accounts for 0.02% of the portfolio, ranked #891.

UBS Group first reported a position in ZBH in Q4 2014 and has held it in 46 quarters since. The position peaked at $134M in Q2 2017. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • UBS Group held 1,373,365 shares of Zimmer Biomet worth $124M as of Q1 2026.
  • UBS Group bought 556,119 Zimmer Biomet shares in Q1 2026, an estimated $51M.
  • Zimmer Biomet made up 0.02% of UBS Group's portfolio in Q1 2026, its #891 holding.
  • UBS Group first reported a position in Zimmer Biomet in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Zimmer Biomet position peaked at $134M in Q2 2017.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.